Page 1 of 6
Permarock Joint Adhesive (PU)
Permarock Joint Adhesive (PU)
Safety Data Sheet according to HSNO Regulations SECTION 1 Identification of the substance / mixture and of the company / undertaking
Product Identifier
Product name:
Chemical Name:
Proper shipping name:
Chemical formula:
Other means of identification:
CAS number:
Relevant identified uses of the substance or mixture and uses advised against
Relevant identified uses:
Details of the supplier of the safety data sheet
Registered company name:
Emergency telephone number
Association / Organisation:
Emergency telephone numbers:
Other emergency telephone numbers:
SECTION 2 Hazards identification
Classification of the substance or mixture
Considered a Hazardous Substance according to the criteria of the New Zealand Hazardous Substances New Organisms legislation. Not regulated for transport of Dangerous

SECTION 3 Composition / information on ingredients
See section below for composition of Mixtures Mixtures
SECTION 4 First aid measures
NZ Poisons Centre 0800 POISON (0800 764 766) | NZ Emergency Services: 111 Description of first aid measures
Eye Contact:
If this product comes in contact with the eyes: Wash out immediately with fresh running water. Ensure complete irrigation of the eye by keeping eyelids apart and away from eye and moving the eyelids by occasionally lifting the upper and lower lids. Seek medical attention without delay; if pain persists or recurs seek medical attention. Removal of contact lenses after an eye injury should only be undertaken by skilled personnel. Skin Contact:
Immediately remove all contaminated clothing, including footwear. Flush skin and hair with running water (and soap if available). Page 2 of 6
Permarock Joint Adhesive (PU)
Seek medical attention in event of irritation. Inhalation:
If fumes or combustion products are inhaled remove from contaminated area. Lay patient down. Keep warm and rested. Prostheses such as false teeth, which may block airway, should be removed, where possible, prior to initiating first aid procedures. Apply artificial respiration if not breathing, preferably with a demand valve resuscitator, bag-valve mask device, or pocket mask as trained. Perform CPR if necessary. Transport to hospital, or doctor, without delay. Following uptake by inhalation, move person to an area free from risk of further exposure. Oxygen or artificial respiration should be administered as needed. Asthmatic-type symptoms may developand may be immediate or delayed up to several hours. Treatment is essential y symptomatic. A physician should be consulted.
If swal owed do NOT induce vomiting.
If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain open airway and prevent aspiration.
Observe the patient carefully.
Never give liquid to a person showing signs of being sleepy or with reduced awareness; i.e. becoming unconscious.
Give water to rinse out mouth, then provide liquid slowly and as much as casualty can comfortably drink.
Seek medical advice.
Indication of any immediate medical attention and special treatment needed
For sub-chronic and chronic exposures to isocyanates: This material may be a potent pulmonary sensitiser which causes bronchospasm even in patients without prior airway hyperreactivity. Clinical symptoms of exposure involve mucosal irritation of respiratory and gastrointestinal tracts. Conjunctival irritation, skin inflammation (erythema, pain vesiculation) and gastrointestinal disturbances occur soon after exposure. Pulmonary symptoms include cough, burning, substernal pain and dyspnoea. Some cross-sensitivity occurs between different isocyanates. Noncardiogenic pulmonary oedema and bronchospasm are the most serious consequences of exposure. Markedly symptomatic patients should receive oxygen, ventilatory support and anintravenous line. Treatment for asthma includes inhaled sympathomimetics (epinephrine [adrenalin], terbutaline) and steroids. Activated charcoal (1 g/kg) and a cathartic (sorbitol, magnesium citrate) may be useful for ingestion. Mydriatics, systemic analgesics and topical antibiotics (Sulamyd) may be used for corneal abrasions. There is no effective therapy for sensitised workers. [Ellenhorn and Barceloux; Medical Toxicology]
NOTE: Isocyanates cause airway restriction in naive individuals with the degree of response dependant on the concentration and duration of exposure. They induce smooth muscle contraction which
leads to bronchoconstrictive episodes. Acute changes in lung function, such as decreased FEV1, may not represent sensitivity.
[Karol & Jin, Frontiers in Molecular Toxicology, pp 56-61, 1992]
Personnel who work with isocyanates, isocyanate prepolymers or polyisocyanates should have a pre-placement medical examination and periodic examinations thereafter, including a pulmonary
function test. Anyone with a medical history of chronic respiratory disease, asthmatic or bronchial attacks, indications of allergic responses, recurrent eczema or sensitisation conditions of the skin
should not handle or work with isocyanates. Anyone who develops chronic respiratory distress when working with isocyanates should be removed from exposure and examined by a physician. Further
exposure must be avoided if a sensitivity to isocyanates or polyisocyanates has developed.
SECTION 5 Firefighting measures
Extinguishing media
Special hazards arising from the substrate or mixture
Fire Incompatibility:
Avoid contamination with oxidising agents i.e. nitrates, oxidising acids, chlorine bleaches, pool chlorine etc. as ignition may result Advice for firefighters
Fire Fighting:
Alert Fire Brigade and tell them location and nature of hazard. Wear breathing apparatus plus protective gloves. Prevent, by any means available, spillage from entering drains or water courses. Use water delivered as a fine spray to control fire and cool adjacent area. Fire/Explosion Hazard:
Combustible. Moderate fire hazard when exposed to heat or flame. When heated to high temperatures decomposes rapidly generating vapour which pressures and may then rupture containers with release of flammable and highly toxic isocyanate vapour. Burns with acrid black smoke and poisonous fumes. SECTION 6 Accidental release measures
Personal precautions, protective equipment and emergency procedures
Minor Spills:
Avoid contact with skin and eyes. Wear impervious gloves and safety goggles. Trowel up/scrape up. Major Spills:
Clear area of personnel and move upwind. Alert Fire Brigade and tell them location and nature of hazard. Wear breathing apparatus plus protective gloves. Prevent, by any means available, spillage from entering drains or water course. Personal Protective Equipment advice is contained in Section 8 of the MSDS.
Page 3 of 6
Permarock Joint Adhesive (PU)
SECTION 7 Handling and storage
Precautions for safe handling
Safe handling
Avoid all personal contact, including inhalation. Wear protective clothing when risk of exposure occurs. Use in a well-ventilated area. Prevent concentration in hollows and sumps. Other information
Store in original containers. Keep containers securely sealed. Store in a cool, dry, well-ventilated area. Store away from incompatible materials and foodstuff containers. Conditions for safe storage, including any incompatibilities
Suitable container:
Packaging as recommended by manufacturer. Check all containers are clearly labelled and free from leaks. Storage incompatibility:
Avoid reaction with water, alcohols and detergent solutions. Isocyanates and thioisocyanates are incompatible with many classes of compounds, reacting exothermically to release toxic gases. Reactions with amines, strong bases, aldehydes,alcohols, alkali metals, ketones, mercaptans, strong oxidisers, hydrides, phenols, and peroxides can cause vigorous releases of heat. Acids and bases initiate polymerisation reactions inthese materials. Package Material Incompatibilities:
SECTION 8 Exposure controls / personal protection
Control parameters
Occupational Exposure Limits (OEL)
Material name
prepolymers, present inthe workplace air asvapours, mist or dust.
Emergency Limits
Original IDLH
Revised IDLH
Exposure controls
Appropriate engineering controls
Engineering controls are used to remove a hazard or place a barrier between the worker and the hazard. Well-designed engineering controls can be highly effective in protecting workers and willtypically be independent of worker interactions to provide this high level of protection.
The basic types of engineering controls are:Process controls which involve changing the way a job activity or process is done to reduce the risk.
Personal protection
Eye and face protection:
Safety glasses with side shields. Chemical goggles. Contact lenses may pose a special hazard; soft contact lenses may absorb and concentrate irritants. A written policy document, describing the wearing of lens or restrictions on use, shouldbe created for each workplace or task.
Skin protection:
Hand protection:
The material may produce skin sensitisation in predisposed individuals. Care must be taken, when removing gloves and other protective equipment, to avoid all possible skin contact. Contaminated leather items, such as shoes, belts and watch-bands should be removed and destroyed. Body protection:
Other protection:
Page 4 of 6
Permarock Joint Adhesive (PU)
Thermal hazards:
Recommended material(s):
Respiratory protection:
Type AK-P Filter of sufficient capacity. (AS/NZS 1716 & 1715, EN 143:2000 & 149:2001, ANSI Z88 or nationalequivalent) SECTION 9 Physical and chemical properties
Information on basic physical and chemical properties
Beige white paste with a slight odour; partly mixes with water.
Physical state
Relative density (Water = 1)
Partition coefficient n-octanol / water
Odour threshold
Auto-ignition temperature (°C)
pH (as supplied)
Decomposition temperature
Melting point / freezing point (°C)
Viscosity (cSt)
Initial boiling point and boiling range (°C)
Molecular weight (g/mol)
Flash point (°C)
Evaporation rate
Explosive properties
Oxidising properties
Upper Explosive Limit (%)
Surface Tension (dyn/cm or mN/m)
Lower Explosive Limit (%)
Volatile Component (%vol)
Vapour pressure (kPa)
Gas group
Solubility in water (g/L)
pH as a solution(1%)
Vapour density (Air = 1)
SECTION 10 Stability and reactivity
Chemical stability:
Product is considered stable and hazardous polymerisation will not occur.
Possibility of hazardous reactions:
Conditions to avoid:
Incompatible materials:
Hazardous decomposition products:
SECTION 11 Toxicological information
Information on toxicological effects
Evidence shows, or practical experience predicts, that the material produces irritation of the respiratory system, in a substantial number of individuals, following inhalation. In contrast to most organs,the lung is able to respond to a chemical insult by first removing or neutralising the irritant and then repairing the damage. The repair process, which initially evolved to protect mammalian lungsfrom foreign matter and antigens, may however, produce further lung damage resulting in the impairment of gas exchange, the primary function of the lungs. Respiratory tract irritation often resultsin an inflammatory response involving the recruitment and activation of many cell types, mainly derived from the vascular system.
Accidental ingestion of the material may be damaging to the health of the individual.
Skin Contact:
Evidence exists, or practical experience predicts, that the material either produces inflammation of the skin in a substantial number of individuals following direct contact, and/or produces significantinflammation when applied to the healthy intact skin of animals, for up to four hours, such inflammation being present twenty-four hours or more after the end of the exposure period. Skin irritation mayalso be present after prolonged or repeated exposure; this may result in a form of contact dermatitis (nonallergic). The dermatitis is often characterised by skin redness (erythema) and swelling (oedema) which may progress to blistering (vesiculation), scaling and thickening of the epidermis. At the microscopic level there may be intercellular oedema of the spongy layer of the skin(spongiosis) and intracellular oedema of the epidermis.
Evidence exists, or practical experience predicts, that the material may cause eye irritation in a substantial number of individuals and/or may produce significant ocular lesions which are presenttwenty-four hours or more after instillation into the eye(s) of experimental animals. Repeated or prolonged eye contact may cause inflammation characterised by a temporary redness (similar towindburn) of the conjunctiva (conjunctivitis); temporary impairment of vision and/or other transient eye damage/ulceration may occur.
Practical evidence shows that inhalation of the material is capable of inducing a sensitisation reaction in a substantial number of individuals at a greater frequency than would be expected from the Pulmonary sensitisation, resulting in hyperactive airway dysfunction and pulmonary allergy may be accompanied by fatigue, malaise and aching. Significant symptoms of exposure may persist forextended periods, even after exposure ceases. Symptoms can be activated by a variety of nonspecific environmental stimuli such as automobile exhaust, perfumes and passive smoking.
Permarock Joint Adhesive (PU)
Page 5 of 6
Permarock Joint Adhesive (PU)
polymeric diphenylmethane diisocyanate
* Value obtained from manufacturer's msdsunless otherwise specified data extracted from RTECS - Register of Toxic Effects of Chemical Substances DIETHYLTOLUENEDIAMINE
The material may produce severe irritation to the eye causing pronounced inflammation. Repeated or prolonged exposure to irritants may produce conjunctivitis.
p-Phenylenediamines are oxidised by the liver microsomal enzymes (S9). Pure p-phenylenediamine is non-mutagenic in but becomes mutagenic after it is oxidized.
The following information refers to contact allergens as a group and may not be specific to this product. Contact allergies quickly manifest themselves as contact eczema, more rarely as urticaria or Quincke's oedema. The pathogenesis of contact eczema involves a cell-mediated (T lymphocytes)immune reaction of the delayed type. Other allergic skin reactions, e.g. contact urticaria, involve antibody-mediated immune reactions.
Acute Toxicity:
Skin Irritation/Corrosion:
Serious Eye Damage/Irritation:
STOT - Single Exposure:
Respiratory or Skin sensitisation:
STOT - Repeated Exposure:
Aspiration Hazard:
SECTION 12 Ecological information
Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
DO NOT discharge into sewer or waterways.
Persistence and degradability
Persistence: Water/Soil
Persistence: Air
Bioaccumulative potential
Mobility in soil
SECTION 13 Disposal considerations
Waste treatment methods
Product / Packaging disposal:
Containers may still present a chemical hazard/ danger when empty. Return to supplier for reuse/ recycling if possible. If container can not be cleaned sufficiently well to ensure that residuals do not remain or if the container cannot be used to store the same product, then puncture containers, to preventre-use, and bury at an authorised landfill. Insure that the disposal of material is carried out in accordance with Hazardous Substances (Disposal) Regulations 2001.
SECTION 14 Transport information
Labels Required:
Marine Pollutant: NO
SECTION 15 Regulatory information
Safety, health and environmental regulations / legislation specific for the substance or mixture
Page 6 of 6
Permarock Joint Adhesive (PU)
This substance is to be managed using the conditions specified in an applicable Group Standard HSR Number
Group Standard
Laboratory Chemicals and Reagent Kits Group Standard 2006 N.O.S. (Subsidiary Hazard) Group Standard 2006 Compressed Gas Mixtures (Subsidiary Hazard) Group Standard 2006 Cleaning Products (Subsidiary Hazard) Group Standard 2006 Lubricants, Lubricant Additives, Coolants and Anti-freeze Agents (Subsidiary Hazard) Group Standard 2006 Aerosols (Subsidiary Hazard) Group Standard 2006 Animal Nutritional and Animal Care Products Group Standard 2006 Fuel Additives (Subsidiary Hazard) Group Standard 2006 Polymers (Subsidiary Hazard) Group Standard 2006 Surface Coatings and Colourants (Subsidiary Hazard) Group Standard 2006 Metal Industry Products (Subsidiary Hazard) Group Standard 2006 Photographic Chemicals (Subsidiary Hazard) Group Standard 2006 Additives, Process Chemicals and Raw Materials (Subsidiary Hazard) Group Standard 2006 Dental Products (Subsidiary Hazard) Group Standard 2006 Food Additives and Fragrance Materials (Subsidiary Hazard) Group Standard 2006 Embalming Products (Subsidiary Hazard) Group Standard 2006 Water Treatment Chemicals (Subsidiary Hazard) Group Standard 2006 Fertilisers (Subsidiary Hazard) Group Standard 2006 Fire Fighting Chemicals Group Standard 2006 Pharmaceutical Active Ingredients Group Standard 2010 Leather and Textile Products (Subsidiary Hazard) Group Standard 2006 Construction Products (Subsidiary Hazard) Group Standard 2006 Corrosion Inhibitors (Subsidiary Hazard) Group Standard 2006 Solvents (Subsidiary Hazard) Group Standard 2006 polymeric diphenylmethane diisocyanate(9016-87-9) is found on the following regulatory lists
"OECD List of High Production Volume (HPV) Chemicals","New Zealand Inventory of Chemicals (NZIoC)","International Agency for Research on Cancer (IARC) - Agents Reviewed by the IARCMonographs","New Zealand Hazardous Substances and New Organisms (HSNO) Act - Classification of Chemicals","New Zealand Hazardous Substances and New Organisms (HSNO) Act -Classification of Chemicals - Classification Data","New Zealand Hazardous Substances and New Organisms (HSNO) Act - Chemicals (single components)","GESAMP/EHS Composite List -GESAMP Hazard Profiles","IMO IBC Code Chapter 17: Summary of minimum requirements","IMO MARPOL 73/78 (Annex II) - List of Noxious Liquid Substances Carried in Bulk","New Zealand diethyltoluenediamine(68479-98-1) is found on the following regulatory lists
"OECD List of High Production Volume (HPV) Chemicals","New Zealand Inventory of Chemicals (NZIoC)","New Zealand Hazardous Substances and New Organisms (HSNO) Act -Classification of Chemicals","New Zealand Hazardous Substances and New Organisms (HSNO) Act - Classification of Chemicals - Classification Data","New Zealand Hazardous Substancesand New Organisms (HSNO) Act - Chemicals (single components)","Regulations concerning the International Carriage of Dangerous Goods by Rail - Table A: Dangerous Goods List - RID 2013(English)","International Maritime Dangerous Goods Requirements (IMDG Code)","International Maritime Dangerous Goods Requirements (IMDG Code) - Substance Index","New Zealand LandTransport Rule: Dangerous Goods 2005 - Schedule 1 Quantity limits","International Air Transport Association (IATA) Dangerous Goods Regulations" SECTION 16 Other information
Other information
Classification of the preparation and its individual components has drawn on official and authoritative sources as well as independent review by the Chemwatch Classification committee using available literature references.
A list of reference resources used to assist the committee may be found at: The (M)SDS is a Hazard Communication tool and should be used to assist in the Risk Assessment. Many factors determine whether the reported Hazards are Risks in the workplace or othersettings. Risks may be determined by reference to Exposures Scenarios. Scale of use, frequency of use and current or available engineering controls must be considered.
This document is copyright. Apart from any fair dealing for the purposes of private study, research, review or criticism, as permitted under the Copyright Act, no part may be reproduced by anyprocess without written permission from CHEMWATCH. TEL (+61 3) 9572 4700.


(microsoft word - \226\362\215\334\217\356\225\36107.doc)

A *Chloroquine *Ethinyl oestradiol *Mebendazole Acetaminophen *Chlorothiazide Ethoheptazine citrate Mecamylamine Acetazolamide Chlorpheniramine Meclizine HCl Acetylcholine Chlorpromazine F Meclozine Acetylsalicylic acid *Cimetidine Famotidine Mefenamic acid Actinomycin D Cisplatin Fenbrufen *Melphalan Acyclovir Clavulanic acid Fenoprofen Mersalyl Adenosine Clofibrate Fentanyl Meperidine monophosp

Important product information

IMPORTANT PRODUCT INFORMATION Dear Doctor: Novartis Animal Health US, Inc. is committed to delivering safe and efficacious veterinary products, and would like to inform you about a recent development involving CLOMICALM® (clomipramine hydrochloride) tablets. Due to potential packaging issues at our manufacturing facility, there is a rare possibility that a wrong tablet may be found in bot

Copyright © 2010 Medicament Inoculation Pdf